Literature DB >> 22189166

Cdk5: a multifaceted kinase in neurodegenerative diseases.

Zelda H Cheung1, Nancy Y Ip.   

Abstract

Since the identification of cyclin-dependent kinase-5 (Cdk5) as a tau kinase and member of the Cdk family almost 20 years ago, deregulation of Cdk5 activity has been linked to an array of neurodegenerative diseases. As knowledge on the etiopathological mechanisms of these diseases evolved through the years, Cdk5 has also been implicated in additional cellular events that are affected under these pathological conditions. From the role of Cdk5 in the regulation of synaptic functions to its involvement in autophagy deregulation, significant insights have been obtained regarding the role of Cdk5 as a key regulator of neurodegeneration. Here, we summarize recent findings on the involvement of Cdk5 in the pathophysiological mechanisms underlying various neurodegenerative diseases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189166     DOI: 10.1016/j.tcb.2011.11.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  103 in total

1.  Neuroprotective effects of Tongmai Yizhi Decoction () against Alzheimer's disease through attenuating cyclin-dependent kinase-5 expression.

Authors:  Jing-Han Feng; Bao-Chang Cai; Wei-Feng Guo; Ming-Yan Wang; Yong Ma; Qiao-Xi Lu
Journal:  Chin J Integr Med       Date:  2016-07-09       Impact factor: 1.978

2.  Neuroprotective activity of pDING in response to HIV-1 Tat.

Authors:  Nune Darbinian; Kamel Khalili; Shohreh Amini
Journal:  J Cell Physiol       Date:  2014-02       Impact factor: 6.384

3.  Identification and characterization of a novel phosphoregulatory site on cyclin-dependent kinase 5.

Authors:  Brett Lee Roach; Jordan Matthew Ngo; Clariss Limso; Koyinsola Bolutife Oloja; Deepali Bhandari
Journal:  Biochem Biophys Res Commun       Date:  2018-09-11       Impact factor: 3.575

4.  Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.

Authors:  Arindam Chatterjee; Stephen J Cutler; Robert J Doerksen; Ikhlas A Khan; John S Williamson
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

5.  Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats.

Authors:  Hani S Hafez; Doaa A Ghareeb; Samar R Saleh; Mariam M Abady; Maha A El Demellawy; Hend Hussien; Nihad Abdel-Monem
Journal:  Psychopharmacology (Berl)       Date:  2017-07-22       Impact factor: 4.530

6.  Oligodendrocyte-specific loss of Cdk5 disrupts the architecture of nodes of Ranvier as well as learning and memory.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Rita R Romito-DiGiacomo; Robert H Miller; Yan Yang
Journal:  Exp Neurol       Date:  2018-05-02       Impact factor: 5.330

Review 7.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

8.  Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK5 and function in pain.

Authors:  Andrei V Chernov; Albert G Remacle; Swathi K Hullugundi; Piotr Cieplak; Mila Angert; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  FEBS J       Date:  2018-08-27       Impact factor: 5.542

Review 9.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  Beneficial effects of polydatin on learning and memory in rats with chronic ethanol exposure.

Authors:  Yan Zhang; Shuang Li; Weifeng Wang; Chunyang Xu; Shuainan Liang; Meng Liu; Wei Hao; Ruiling Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.